Sridhar Kosaraju, Director at 10x Genomics, Inc. (TXG), sold 1,500 shares at $163.25 ($243K) on 2021-08-23, disclosed to the SEC on 2021-08-25.
Open-market sale of $243k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.72 | 200 | $32K | 13.0% |
| 2 | $160.56 | 100 | $16K | 6.6% |
| 3 | $162.27 | 500 | $81K | 33.4% |
| 4 | $163.25 | 600 | $98K | 40.3% |
| 5 | $164.05 | 100 | $16K | 6.7% |
| Total | $162.06 avg | 1,500 |
| $243K |
| 100% |
| Filing → |
| TXG | SELL | 2021-10-27 | $349K | — | Filing → |
| TXG | SELL | 2021-09-24 | $239K | — | Filing → |
| TXG | SELL | 2021-07-26 | $359K | — | Filing → |